https://medicaldialogues.in/oncology/news/blinatumomab-promising-for-treatment-of-aggressive-infant-leukemia-with-816-disease-free-survival-rate-nejm-111178
Blinatumomab promising for treatment of aggressive infant leukemia with 81.6% disease-free survival rate: NEJM